ABBOTT LABORATORIES — Director's Dealing 2015

Mar 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2013-10-31

Reporting Person: Doyle Katherine C. (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-10-31	Common shares without par value	P	102	$36.708	Acquired	43429	Direct
2013-12-03	Common shares without par value	P	4	$37.50	Acquired	43433	Direct
2014-02-03	Common shares without par value	S	1	$35.93	Disposed	43432	Direct
2014-03-14	Common shares without par value	P	52	$39.106	Acquired	43484	Direct
2014-04-15	Common shares without par value	S	10	$37.582	Disposed	43474	Direct

Footnotes

F1: Purchase was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's sale of 200 shares of Abbott common shares at a price of $39.015 per share (including transaction costs), or $38.999 per share (excluding transaction costs), which was reported on March 4, 2014. The reporting person has paid to Abbott $239.70, representing the full amount of the profit realized in connection with these transactions, less transaction costs.